You Won’t Believe How Much $10,000 Invested in Canopy Growth (TSX:WEED) in 2014 Is Worth Today

A $10,000 investment made in Canopy Growth Corp (TSX:WEED)(NYSE:CGC) back in June 2014 would have made an investor pretty wealthy.

| More on:

It’s no secret shares of Canopy Growth (TSX:WEED)(NYSE:CGC) have done well over the last five years. Everyone knows this.

Canopy has been through a lot of changes over the last half-decade, working towards its stated goal of becoming Canada’s dominant pot company. And it has succeeded, building up everything from production to its own finished products — complete with slick branding — and even rolling out its own retail presence in provinces that allow private ownership of marijuana shops.

It’s little wonder why the stock has become the go-to name in the sector. It’s the biggest, and bulls argue it’s the best run as well.

One thing I like best about the company is that CEO Bruce Linton and his management team always have their foot on the gas pedal. Canopy is relentlessly growing, investing cash almost as fast as they can raise it. One recent investment saw the company commit $500 million towards hemp production in Idaho — facilities that can easily be converted to growing marijuana once it becomes legal across the U.S. Bulls say this is only a matter of time.

Let’s take a closer look at Canopy’s performance over the last five years and just how much money an investor would have made if they put a mere $10,000 into the company back then. You won’t believe the results.

Canada’s top stock

No other stock on the TSX has done better than Canopy Growth over the last five years.

Back in 2014, the company wasn’t much more than a few employees, a tiny market cap, and a bold idea. Some investors saw the long-term potential in medical marijuana, but few saw just how close we were to legalizing the drug.

Liberal party leader Justin Trudeau pledged to legalize cannabis if his party was elected in 2015, but many investors saw this as an empty election promise designed to get younger voters excited about a Liberal government. Trudeau easily defeated incumbent Prime Minister Stephen Harper and the legalization plan was put in motion.

We’ve also seen a remarkable shift in attitude about cannabis over the last few years. Folks staunchly opposed to legalization have softened their stance. Formerly secret users are more open about their habit. You’re often greeted with the pungent smell of marijuana when walking down a busy Canadian street nowadays.

And Canopy Growth investors have been the major beneficiaries of this trend.

On June 6, 2014, Canopy Growth shares were worth a mere $2.75 each. As I type this, the stock is trading for $53.80. This translates into a massive 1,891% return.

It’s even more striking when you look at the annual return. Canopy Growth has compounded investor money by more than 89% each year since 2014. That’s enough to turn a $10,000 investment into one worth $199,087.

It would take an investor earning 10% a year approximately 30 years to turn $10,000 into $200,000. It took Canopy Growth investors just five years.

Can Canopy do it again?

The short answer is no. Canopy cannot grow another 1,891% in the next five years. It is simply too big today.

But that doesn’t mean it’s a poor investment choice today. The stock could easily double or triple between now and 2024. That would still be a pretty satisfactory result.

As bulls have argued for years, the legal pot market is really just getting started. And Canopy is in a great position to benefit from that. Patient investors should do well on the stock. Just maybe not as well as before.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Nelson Smith has no position in any of the stocks mentioned.

More on Cannabis Stocks

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »